Number of the records: 1
Mebendazole prodrugs with enhanced solubility and oral bioavailability
- 1.
SYSNO 0580041 Title Mebendazole prodrugs with enhanced solubility and oral bioavailability Author(s) Slusher, B. (US)
Rais, R. (US)
Riggins, G. (US)
Majer, Pavel (UOCHB-X) [390/39]
Tichý, Tomáš (UOCHB-X) [390/39] RID
Vávra, Jan (UOCHB-X) [390/39] RID
Jančařík, Andrej (UOCHB-X) [390/39] ORCID, RID
Tenora, Lukáš (UOCHB-X) [390/39] ORCIDIssue data 2023 Name of the owner The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i Date of the patent acceptance 14.09.2023 Patent no. or utility model no. or industrial design no. AU2019216757 Code of the issuer name AU001 - IP Australia Phillip ACT Territorial Protection NEU - národní patent v zemi mimo EU
PCT - mezinárodní patentová ochrana dle Smlouvy o patentové spolupráciDocument Type Patentový dokument Institutional support UOCHB-X - RVO:61388963 Language eng Keywords mebendazole * prodrug * oral bioavailability URL https://worldwide.espacenet.com/patent/search/family/067549070/publication/AU2019216757B2?q=AU2019216757B2 Permanent Link https://hdl.handle.net/11104/0348822
Number of the records: 1